Filed: 2/14/2024ACC: 0001104659-24-023659
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $1.46B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$1.46B
Total AUM (reported)
117.72M
Total Shares
Allocation by class
COM$1.36B93.0%
COM NEW$64.72M4.4%
COM SHS$18.43M1.3%
SPONSORED ADS$10.68M0.7%
ORDINARY SHARES$7.65M0.5%
Portfolio Concentration
Top 3$583.12M40.0%
4–10$413.30M28.3%
11–25$388.43M26.6%
Rest$73.21M5.0%
Top 3 weight
40.0%
Top 10 weight
68.3%
Voting Authority Distribution
Total shares with voting rights: 117.72M
Sole
Full voting authority
117.72M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
RAYZEBIO INC
SOLEShares4.03M
TypeSH
Market value$250.57M
17.19%
Sole
4.03M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$237.30M
16.28%
Sole
8.49M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares3.40M
TypeSH
Market value$95.25M
6.53%
Sole
3.40M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.88M
TypeSH
Market value$84.56M
5.80%
Sole
3.88M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares3.42M
TypeSH
Market value$69.37M
4.76%
Sole
3.42M
Shared
0.00
None
0.00
MERUS N V
SOLEShares2.15M
TypeSH
Market value$59.08M
4.05%
Sole
2.15M
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares2.56M
TypeSH
Market value$58.20M
3.99%
Sole
2.56M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.37M
TypeSH
Market value$51.06M
3.50%
Sole
2.37M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares4.09M
TypeSH
Market value$50.14M
3.44%
Sole
4.09M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares2.95M
TypeSH
Market value$40.90M
2.80%
Sole
2.95M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares7.78M
TypeSH
Market value$34.68M
2.38%
Sole
7.78M
Shared
0.00
None
0.00
HILLEVAX INC
SOLEShares2.08M
TypeSH
Market value$33.30M
2.28%
Sole
2.08M
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares2.07M
TypeSH
Market value$29.48M
2.02%
Sole
2.07M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares4.50M
TypeSH
Market value$29.19M
2.00%
Sole
4.50M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$28.91M
1.98%
Sole
2.17M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares4.68M
TypeSH
Market value$27.54M
1.89%
Sole
4.68M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares1.89M
TypeSH
Market value$27.47M
1.88%
Sole
1.89M
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares11.33M
TypeSH
Market value$26.28M
1.80%
Sole
11.33M
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares627.79K
TypeSH
Market value$25.84M
1.77%
Sole
627.79K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares3.23M
TypeSH
Market value$24.77M
1.70%
Sole
3.23M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares495.98K
TypeSH
Market value$22.80M
1.56%
Sole
495.98K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares2.43M
TypeSH
Market value$22.34M
1.53%
Sole
2.43M
Shared
0.00
None
0.00
APPLIED THERAPEUTICS INC
SOLEShares6.25M
TypeSH
Market value$20.94M
1.44%
Sole
6.25M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares10.41M
TypeSH
Market value$18.43M
1.26%
Sole
10.41M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares3.50M
TypeSH
Market value$16.45M
1.13%
Sole
3.50M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RAYZEBIO INCSOLE | COM | 4.03M | SH | $250.57M 17.19% | 4.03M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $237.30M 16.28% | 8.49M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 3.40M | SH | $95.25M 6.53% | 3.40M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.88M | SH | $84.56M 5.80% | 3.88M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 3.42M | SH | $69.37M 4.76% | 3.42M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 2.15M | SH | $59.08M 4.05% | 2.15M | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 2.56M | SH | $58.20M 3.99% | 2.56M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.37M | SH | $51.06M 3.50% | 2.37M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 4.09M | SH | $50.14M 3.44% | 4.09M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 2.95M | SH | $40.90M 2.80% | 2.95M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 7.78M | SH | $34.68M 2.38% | 7.78M | 0.00 | 0.00 |
HILLEVAX INCSOLE | COM | 2.08M | SH | $33.30M 2.28% | 2.08M | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | COM | 2.07M | SH | $29.48M 2.02% | 2.07M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 4.50M | SH | $29.19M 2.00% | 4.50M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $28.91M 1.98% | 2.17M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 4.68M | SH | $27.54M 1.89% | 4.68M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 1.89M | SH | $27.47M 1.88% | 1.89M | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 11.33M | SH | $26.28M 1.80% | 11.33M | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 627.79K | SH | $25.84M 1.77% | 627.79K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 3.23M | SH | $24.77M 1.70% | 3.23M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 495.98K | SH | $22.80M 1.56% | 495.98K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 2.43M | SH | $22.34M 1.53% | 2.43M | 0.00 | 0.00 |
APPLIED THERAPEUTICS INCSOLE | COM | 6.25M | SH | $20.94M 1.44% | 6.25M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 10.41M | SH | $18.43M 1.26% | 10.41M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 3.50M | SH | $16.45M 1.13% | 3.50M | 0.00 | 0.00 |
Page 1 of 2